Newsroom

Sorted by: Latest

-

Planet and Tony Blair Institute for Global Change Enable Data-Driven Policy for the Government of Zanzibar

SAN FRANCISCO--(BUSINESS WIRE)--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about change on Earth, today announced the successful completion of their pilot project with the Tony Blair Institute for Global Change (TBI) to help enable informed decision-making for the government of Zanzibar. This 12-month initiative aimed to equip government leaders with access to Planet satellite data and the digital skills to interpret geospatial data and apply its insights to real-...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3 - Bakkavor Group PLC

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Panasonic Professional Video & Audio Systems Names Caroline Niedzwiecki as Director of Sales

NEWARK, N.J.--(BUSINESS WIRE)--Panasonic Professional Video & Audio Systems Names Caroline Niedzwiecki as Director of Sales...
-

January Digital Becomes A TikTok Badged Agency Partner

NEW YORK--(BUSINESS WIRE)--January Digital, the Marketing Leadership Company, has officially been recognized as a badged TikTok Agency Partner, joining a select group of agencies that have demonstrated outstanding expertise in leveraging TikTok’s platform to drive exceptional results for brands. January Digital was selected based on the agency’s track record of driving measurable growth for brands by integrating platform-native creative, strategic media planning, and continuous testing. The bad...
-

TCW Launches $370 Million Core Plus Fixed Income ETF

LOS ANGELES--(BUSINESS WIRE)--The TCW Group announced that it has completed the conversion of the TCW MetWest Intermediate Bond Fund into a new ETF, the TCW Core Plus Bond ETF....
-

John Lippmann Joins Barings as Head of U.S. Real Estate Capital Markets

CHARLOTTE, N.C.--(BUSINESS WIRE)--Barings, one of the world’s largest diversified real estate investment managers, today announced that John Lippmann has joined Barings as Head of U.S. Real Estate Capital Markets, effective immediately. Lippmann will lead the strategy and execution of asset and fund leverage for U.S. debt and equity real estate portfolios and will support various strategic growth initiatives. He will be based in New York and will report to Shawn Kimble, Head of U.S. & Europ...
-

SentinelOne Brings Singularity AI SIEM to the AWS Marketplace, Opening a Massive New Channel for the Company’s Fastest Growing Offering

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SentinelOne's Singularity™ AI SIEM–is now available on AWS Marketplace....
-

New CSC Survey Finds Overwhelming Majority of CISOs Anticipate Surge in Cyber Attacks Over the Next Three Years

WILMINGTON, Del.--(BUSINESS WIRE)--New CSC survey finds overwhelming majority of CISOs anticipate surge in cyber attacks over the next three years....
-

Trivest Announces Sale of Unosquare

MIAMI--(BUSINESS WIRE)--Trivest Partners (“Trivest”), a leading private equity firm focused exclusively on investing in founder and family-owned businesses, has completed the successful sale of its portfolio company Unosquare, LLC (“Unosquare ” or the “Company”) to Ridgemont Equity Partners. Unosquare partnered with Trivest’s non-control fund, Trivest Growth Investment Fund (“TGIF”), in late 2020. Since launching the non-control extension nearly a decade ago, Trivest has completed 27 non-contro...
-

Imbrium Therapeutics to Showcase Pipeline Assets Open for Partnership at the BIO International Convention 2025

STAMFORD, Conn.--(BUSINESS WIRE)--Imbrium Therapeutics L.P. (“Imbrium”), a clinical-stage biopharmaceutical company, is presenting pipeline developments at the BIO International Convention on Wednesday, June 18, at 9:15 a.m. in Room 153B. Imbrium is actively seeking partnerships to advance the development of investigational therapeutics for multiple indications across several disease areas including genitourinary disorders, substance use disorders, and cancerous malignancies. Imbrium is discuss...